Home > Historical Performance > Historical Transaction Report

Transaction Details

Company: Eon Labs
Yahoo Beta:0.90
Industry:Biotechnology & Drugs

Company Description:  Eon Labs, Inc. is engaged in developing, marketing, and distributing generic prescription drugs.

Purchase Date:29 Jan 2003 Sale Date:08 Mar 2004
Purchase Price:$22.03 Sale Price:$60.17
  --Split Adjusted:$22.03  --Split Adjusted:$60.17
Shares Purchased:200 Shares Sold:200
  --Split Adjusted:200  --Split Adjusted:200
Transaction Fee:$100.47 Transaction Fee:$168.52
Price Range (6 Months Prior):    Price Range (6 Months After):    
High$24.38 High$0.00
Date22 Dec 2002 Date01 Jan 1996
Low$17.79 Low$0.00
Date14 Nov 2002 Date01 Jan 1996
S&P (Purchase Date):$864.36 S&P (Sale Date):$1,157.00

Timing:  Stock is trading towards the upper part of the range over the last six months.
Reason:  The company has attractive profitability, ROA, ROE, and PE mulitple. We believe the generic drug market presents an good investment opportunity.

Reason:  Eon Lab's stock price has increased dramatically during the time we have owned the stock. The current PE is about 40 and we don't believe earnings will grow dramatically enough in the near term to justify the current price.

S&P Gain: 33.86 % Annualized Gain: 33.13%
Stock Gain: 173.13 % Annualized Gain: 168.01%

Net Holding Return ($): $7,359.01
Net Holding Return (%): 163.3 %